PAR-25-141-Full-Announcement.html

This is a Federal Grant Opportunity announcement for PAR-25-141, titled "NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)," managed by the Department of Health and Human Services National Institutes of Health. The opportunity is a reissue of PAR-24-208, with changes only to Section V (Application Review Information) to align with NIH's Simplified Review process for research grant applications.

The grant falls under CFDA 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research) and uses a cooperative agreement funding instrument. Eligible applicants include higher education institutions, government entities, nonprofits, for-profit organizations, tribal organizations, and small businesses. The opportunity supports NIAMS's mission to advance research in arthritis, musculoskeletal, and skin diseases, including causes, treatment, and prevention, as well as training basic and clinical scientists in these fields.